NZ333180A - Topical aqueous gel composition containing a combination of a non-steroidal anti-inflammatory drug, a xanthine derivative, a gelling agent, water and a cosolvent - Google Patents

Topical aqueous gel composition containing a combination of a non-steroidal anti-inflammatory drug, a xanthine derivative, a gelling agent, water and a cosolvent

Info

Publication number
NZ333180A
NZ333180A NZ333180A NZ33318097A NZ333180A NZ 333180 A NZ333180 A NZ 333180A NZ 333180 A NZ333180 A NZ 333180A NZ 33318097 A NZ33318097 A NZ 33318097A NZ 333180 A NZ333180 A NZ 333180A
Authority
NZ
New Zealand
Prior art keywords
weight
water
xanthine derivative
steroidal anti
inflammatory drug
Prior art date
Application number
NZ333180A
Other languages
English (en)
Inventor
Nigel John Leeves
Francois Riahi
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NZ333180A publication Critical patent/NZ333180A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ333180A 1996-06-27 1997-06-24 Topical aqueous gel composition containing a combination of a non-steroidal anti-inflammatory drug, a xanthine derivative, a gelling agent, water and a cosolvent NZ333180A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9613457.2A GB9613457D0 (en) 1996-06-27 1996-06-27 Pharmaceutical compositions
PCT/US1997/011205 WO1997049405A1 (en) 1996-06-27 1997-06-24 Topical gel composition containing a combination of a nsaid and a xanthine derivative

Publications (1)

Publication Number Publication Date
NZ333180A true NZ333180A (en) 2000-09-29

Family

ID=10795959

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ333180A NZ333180A (en) 1996-06-27 1997-06-24 Topical aqueous gel composition containing a combination of a non-steroidal anti-inflammatory drug, a xanthine derivative, a gelling agent, water and a cosolvent

Country Status (14)

Country Link
EP (1) EP0973522A1 (no)
JP (1) JPH11513037A (no)
KR (1) KR20000022245A (no)
AU (1) AU3643897A (no)
BR (1) BR9709997A (no)
CA (1) CA2258199A1 (no)
CZ (1) CZ409198A3 (no)
GB (1) GB9613457D0 (no)
HU (1) HUP9903835A3 (no)
IL (1) IL127426A0 (no)
NO (1) NO986042L (no)
NZ (1) NZ333180A (no)
TR (1) TR199802701T2 (no)
WO (1) WO1997049405A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274592B1 (en) * 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US9012402B1 (en) 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
US10821075B1 (en) 2017-07-12 2020-11-03 James Blanchard Compositions for topical application of a medicaments onto a mammalian body surface

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations

Also Published As

Publication number Publication date
WO1997049405A1 (en) 1997-12-31
CZ409198A3 (cs) 1999-04-14
NO986042D0 (no) 1998-12-22
CA2258199A1 (en) 1997-12-31
GB9613457D0 (en) 1996-08-28
HUP9903835A3 (en) 2001-03-28
BR9709997A (pt) 1999-08-10
HUP9903835A2 (hu) 2000-10-28
TR199802701T2 (xx) 1999-03-22
EP0973522A1 (en) 2000-01-26
IL127426A0 (en) 1999-10-28
AU3643897A (en) 1998-01-14
JPH11513037A (ja) 1999-11-09
KR20000022245A (ko) 2000-04-25
NO986042L (no) 1999-02-26

Similar Documents

Publication Publication Date Title
NO2006007I1 (no) (+)-(S)-2-(3-benzoylfenyl)-propionsyre-trometaminsalt(deksketoprofentrometamol)
DK0669129T3 (da) Ekspanderbare lægemiddelformer med kontrolleret afgivelse af aktivt stof
DE60036611D1 (de) Indol-derivate als antientzündungs wirkstoffe
ES2120070T3 (es) Esteres nitricos dotados de una actividad anti-inflamatoria y/o analgesica y su procedimiento de preparacion.
ES2019435B3 (es) Dispersiones acuosas de polimeros estables al almacenamiento.
DK1024795T3 (da) Formuleringer med reguleret frigivelse
NZ333180A (en) Topical aqueous gel composition containing a combination of a non-steroidal anti-inflammatory drug, a xanthine derivative, a gelling agent, water and a cosolvent
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
JPH026407A (ja) 炎症抑制剤ゲル
DK0641759T3 (da) Anvendelse af aromatiske carboxylsyrederivater til fremstilling af farmaceutiske præparater
ITTO920303A1 (it) Composizione farmaceutica antiinfiammatoria
ES260595A1 (es) Un metodo para revestir tabletas y similares con una delgada pelicula plastica de color estable
AU7096096A (en) Indole derivatives and medical application thereof
NO975127L (no) Anvendelse av ikke-steroidale antiinflammatoriske midler for å forbedre den fysiologiske forlikelighet av partikulære farmasöytiske preparater
CA2380128A1 (en) Plasters containing 4-biphenylacetic acid
ES2192337T3 (es) Procedimiento para la preparacion de dispersiones de poli(esteres vinilicos), libres de disolventes, que tienen una resistencia aumentada al agua.
BR9713963A (pt) Processo para preparação de um gel de copolìmero reticulado de anidrido maleico e um alquil vinil éter
KR910014337A (ko) d-2-(6-메톡시-2-나프릴)-프로피온산의 광학활성 유도체와 이것을 함유한 약제학적 조성물
KR880012518A (ko) 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물
JPS6463552A (en) 4-biphenylylacetic acid ester-cyclodextrin inclusion compound
SE9001823L (sv) Fenoxisyror foer anvaendning som terapeutiskt aktiva substanser
JPS5295630A (en) Propionic acid and pyruvic acid derivatives